Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Fluorescent Nanoparticles Image Tumor Marker in Animals

Abstract:
Since 2004 the U.S. Food and Drug Administration has approved three new-generation anticancer therapies that target epidermal growth factor receptor (EGFR), a protein that is greatly overexpressed on certain types of tumors, including some forms of colorectal and lung cancer. For patients with EGFR-positive tumors, these drugs can be lifesavers, but at present, there is no good way to predict who will respond to anti-EGFR therapy. That may change, though, thanks to the development of two quantum dot-based systems that can image EGFR expression in living animals.

Fluorescent Nanoparticles Image Tumor Marker in Animals

Bethesda , MD | Posted on February 19th, 2008

Reporting its work in the journal Clinical Cancer Research, a team of investigators at the M.D. Anderson Cancer Center, led by Sunil Krishnan, M.D., and Juri Gelovani M.D., Ph.D., describes its design of a near-infrared quantum dot linked to epidermal growth factor and used to image tumors that overexpress EGFR in a mouse model of human colon cancer. Binding assays showed that this construct was capable of recognizing and binding to EGFR with only a slight reduction in affinity compared with native epidermal growth factor. However, activity assays showed that the targeted quantum dot did not activate EGFR, which could cause complications for a potential imaging agent by triggering unwanted tumor cell growth.

Using a mouse model of human colon cancer, the investigators then assessed this quantum dot's utility as an in vivo imaging agent. After injecting tumor-bearing animals with the quantum dots, the investigators tracked the distribution of these probes using a commercial fluorescence imaging system. As a control, the researchers injected some animals with an untargeted quantum dot. Within 3 minutes of injection, the researchers were able to observe the quantum dots distributing throughout the body, but over the next hour, only the targeted quantum dots accumulated within tumors. By 24 hours after injection, fluorescence levels in animals for both targeted and untargeted quantum dots had dropped to near zero.

Moungi Bawendi, Ph.D., and colleagues at the Massachusetts Institute of Technology have also developed an EGFR-targeted quantum dot capable of imaging live cells, although his group's efforts to date have focused on working out new chemical methods for preparing compact biocompatible quantum dots. These methods, which should also simplify the development of a wide range of targeted quantum dot imaging probes, appear in a paper published in the Journal of the American Chemical Society.

The work conducted by Dr. Krishnan, Dr. Gelovani, and their collaborators is detailed in the paper "Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe." An abstract of this paper is available through PubMed.

Dr. Bawendi and group's work is described in the paper "Compact biocompatible quantum dots functionalized for cellular imaging." Dr. Bawendi is a member of the MIT-Harvard Center of Cancer Nanotechnology Excellence, and this work was funded in part by the NCI's Alliance for Nanotechnology in Cancer. An abstract of this paper is available through PubMed.

####

About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © National Cancer Institute

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Abstact-“Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe.”

Abstract-“Compact biocompatible quantum dots functionalized for cellular imaging.”

Related News Press

News and information

Measuring the Smallest Magnets July 28th, 2014

WITec to host the 11th Confocal Raman Imaging Symposium from September 29th - October 1st in Ulm, Germany July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Nanomedicine

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

New imaging agent provides better picture of the gut July 25th, 2014

Scientists Test Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer July 25th, 2014

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

Discoveries

Seeing is bead-lieving: Rice University scientists create model 'bead-spring' chains with tunable properties July 28th, 2014

Measuring the Smallest Magnets July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Stanford team achieves 'holy grail' of battery design: A stable lithium anode - Engineers use carbon nanospheres to protect lithium from the reactive and expansive problems that have restricted its use as an anode July 27th, 2014

Announcements

Measuring the Smallest Magnets July 28th, 2014

WITec to host the 11th Confocal Raman Imaging Symposium from September 29th - October 1st in Ulm, Germany July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE